GLP-1 treatments reduce cancer risk in diabetes patients
GMA News Online — July 5, 2024, 08:00 PM UTC
Summary: A study shows type 2 diabetes patients on GLP-1 treatments like Ozempic have lower risk of 10 obesity-related cancers compared to those on insulin. The research, analyzing 1.6 million patients, suggests potential cancer prevention benefits. Newer GLP-1 drugs are more effective at controlling blood sugar and inducing weight loss. FDA-approved Ozempic in 2017. Studies on these drugs for cancer prevention are recommended.
Article metrics
The article metrics are deprecated.
I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.